SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-23-031293
Filing Date
2023-11-09
Accepted
2023-11-09 16:44:17
Documents
48
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q vtgn20230930_10q.htm   iXBRL 10-Q 1019296
2 EXHIBIT 10.2 ex_594538.htm EX-10.2 8712
3 EXHIBIT 31.1 ex_590771.htm EX-31.1 8040
4 EXHIBIT 31.2 ex_590772.htm EX-31.2 8213
5 EXHIBIT 32 ex_590773.htm EX-32 5097
  Complete submission text file 0001437749-23-031293.txt   3635454

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA vtgn-20230930.xsd EX-101.SCH 35227
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vtgn-20230930_cal.xml EX-101.CAL 25838
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vtgn-20230930_def.xml EX-101.DEF 269376
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE vtgn-20230930_lab.xml EX-101.LAB 192830
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vtgn-20230930_pre.xml EX-101.PRE 278354
42 EXTRACTED XBRL INSTANCE DOCUMENT vtgn20230930_10q_htm.xml XML 284670
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
Vistagen Therapeutics, Inc. (Filer) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-37761 | Film No.: 231393360
SIC: 2834 Pharmaceutical Preparations